Skip to Main Content

Author Details

Eric A Klein
Cleveland Clinic
1984
672
95
PMIDPaper TitleJournal TitlePublished Year
36630568Impact of Prostate Urethral Lift Device on Prostate Magnetic Resonance Image Quality.J Urol2023
37801613Prostate Cancer Progression Relies on the Mitotic Kinase Citron Kinase.Cancer Res2023
37655657Elevated periprostatic venous testosterone correlates with prostate cancer progression after radical prostatectomy.J Clin Invest2023
37945903Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.Nat Genet2023
37811334Digital pathology operations at a tertiary cancer center: Infrastructure requirements and operational cost.J Pathol Inform2023
37255363Dying To Find Out: The Cost of Time at the Dawn of the Multicancer Early Detection Era.Cancer Epidemiol Biomarkers Prev2023
37467458Performance of a Cell-Free DNA-Based Multi-cancer Detection Test in Individuals Presenting With Symptoms Suspicious for Cancers.JCO Precis Oncol2023
36965817Using IsoPSA With Prostate Imaging Reporting and Data System Score May Help Refine Biopsy Decision Making in Patients With Elevated PSA.Urology2023
37031713Multicancer Early Detection.Clin Gastroenterol Hepatol2023
37396490Novel radiomic analysis on bi-parametric MRI for characterizing differences between MR non-visible and visible clinically significant prostate cancer.Eur J Radiol Open2023
36647826BMX controls 3βHSD1 and sex steroid biosynthesis in cancer.J Clin Invest2023
36745009The combination of prostate MRI PI-RADS scoring system and a genomic classifier is associated with pelvic lymph node metastasis at the time of radical prostatectomy.Br J Radiol2023
36872133Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry.Eur Urol2023
36804550Development of a Clinical-scholar Index Score for Measuring Academic Contributions in Urology.Urology2023
36804443IsoPSA Performance Characteristics are Unaffected by 5-Alpha Reductase Inhibitors or Alpha-Blockers: Results From the IsoPSA Validation Study.Urology2023
36796953The Promise of Multicancer Early Detection.Am J Med2023
36894715Allyship for women in urology.Nat Rev Urol2023
36484816When to order genomic tests: development and external validation of a model to predict high-risk prostate cancer at the genotypic level.World J Urol2023
33162316Influence of Enema and Dietary Restrictions on Prostate MR Image Quality: A Multireader Study.Acad Radiol2022
35680047Elevated IsoPSA Selects for Clinically Significant Prostate Cancer Without a Preference for Any Particular Adverse Histopathologic or Radiographic Feature.Urology2022
35843353Detection of Clinically Significant Index Prostate Cancer Using Micro-ultrasound: Correlation With Radical Prostatectomy.Urology2022
35772481Comparing Pathologic and Survival Outcomes Between Primary and Secondary Muscle Invasive Bladder Cancer When Treated by Radical Cystectomy With or Without Neoadjuvant Chemotherapy.Urology2022
35508258Transperineal Prostate Biopsy is Associated With Lower Tissue Core Pathogen Burden Relative to Transrectal Biopsy: Mechanistic Underpinnings for Lower Infection Risk in the Transperineal Approach.Urology2022
35840465Clinical validation of IsoPSA, a single parameter, structure-focused assay for improved detection of prostate cancer: A prospective, multicenter study.Urol Oncol2022
35536859Hypoxia-Reoxygenation Couples 3βHSD1 Enzyme and Cofactor Upregulation to Facilitate Androgen Biosynthesis and Hormone Therapy Resistance in Prostate Cancer.Cancer Res2022
35638091Variation in Molecularly Defined Prostate Tumor Subtypes by Self-identified Race.Eur Urol Open Sci2022
35662504Transcriptomic Features of Cribriform and Intraductal Carcinoma of the Prostate.Eur Urol Focus2022
35626398The Promise of Multicancer Early Detection. Comment on Pons-Belda et al. Can Circulating Tumor DNA Support a Successful Screening Test for Early Cancer Detection? The Grail Paradigm. <i>Diagnostics</i> 2021, <i>11</i>, 2171.Diagnostics (Basel)2022
37145695IsoPSA<sup>®</sup> Reduces Provider Recommendations for Biopsy and Magnetic Resonance Imaging in Men with Total Prostate Specific Antigen ⿥4 ng/ml: A Real-World Observational Clinical Utility Study.Urol Pract2022
364121225-Hydroxyeicosatetraenoic Acid Controls Androgen Reduction in Diverse Types of Human Epithelial Cells.Endocrinology2022
35970657Single-port Robotic Transvesical Partial Prostatectomy for Localized Prostate Cancer: Initial Series and Description of Technique.Eur Urol2022
35970656Re: Sabrina H. Rossi, Grant D. Stewart. Re: Clinical Validation of a Targeted Methylation-based Multi-cancer Early Detection Test Using an Independent Validation Set. Eur Urol. 2022;82:442-443.Eur Urol2022
33608234How Should Molecular Markers and Magnetic Resonance Imaging Be Used in the Early Detection of Prostate Cancer?Eur Urol Oncol2022
35145197Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25â¿¿mm diameter as an optimal definition for "large" cribriform prostatic adenocarcinoma.Mod Pathol2022
35118852Multicancer early detection.Clin Chem Lab Med2022
35031163A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry.Eur Urol2022
34993496Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.HGG Adv2022
34824014Validating the association of adverse pathology with distant metastasis and prostate cancer mortality 20-years after radical prostatectomy.Urol Oncol2022
34587771Reply by Authors.J Urol2022
34433304Prospective Multicenter Comparison of Open and Robotic Radical Prostatectomy: The PROST-QA/RP2 Consortium.J Urol2022
344333015α-Reductase Inhibitors Are Associated with Reduced Risk of SARS-CoV-2 Infection: A Matched-Pair, Registry-Based Analysis.J Urol2022
34728381Optimization of prostate biopsy - Micro-Ultrasound versus MRI (OPTIMUM): A 3-arm randomized controlled trial evaluating the role of 29⿯MHz micro-ultrasound in guiding prostate biopsy in men with clinical suspicion of prostate cancer.Contemp Clin Trials2022
34656435<sup>125</sup>I Interstitial brachytherapy with or without androgen deprivation therapy among unfavorable-intermediate and high-risk prostate cancer.Brachytherapy2022
34711629Gut Microbiome-Dependent Metabolic Pathways and Risk of Lethal Prostate Cancer: Prospective Analysis of a PLCO Cancer Screening Trial Cohort.Cancer Epidemiol Biomarkers Prev2022
32897764Androgen Deprivation Therapy in Men with Prostate Cancer Does Not Affect Risk of Infection with SARS-CoV-2.J Urol2021
37145424Decision Analysis Model Comparing Cost of IsoPSAâ¿¢ vs Repeat Biopsy for Detection of Clinically Significant Prostate Cancer in Men with Previous Negative Findings on Biopsy.Urol Pract2021
33493001Multicenter Comparison of 17-Gene Genomic Prostate Score as a Predictor of Outcomes in African American and Caucasian American Men with Clinically Localized Prostate Cancer.J Urol2021
33713608Discovery and fine-mapping of height loci via high-density imputation of GWASs in individuals of African ancestry.Am J Hum Genet2021
33928239Prostate cancer in young men represents a distinct clinical phenotype: gene expression signature to predict early metastases.J Transl Genet Genom2021
33531653A comparative study of PCS and PAM50 prostate cancer classification schemes.Prostate Cancer Prostatic Dis2021
  • 1 - 50 of 672

Recommended Authors

Adam B Weiner
Northwestern University Feinberg School of Medicine
Career Start Year 2013
Number of shared co-authors 43
Giorgio Gandaglia
IRCCS San Raffaele Scientific Institute, Italy Vita-Salute San Raffaele University
Career Start Year 2012
Number of shared co-authors 43
Devin N Patel
university of california san diego School of Medicine
Career Start Year 2011
Number of shared co-authors 5
Izak Faiena
Columbia University Medical Center
Career Start Year 2010
Number of shared co-authors 6
Michael A Liss
University of Texas Health San Antonio
Career Start Year 2008
Number of shared co-authors 22
Roderick C N van den Bergh
St. Antonius Hospital
Career Start Year 2007
Number of shared co-authors 21
Declan G Murphy
Peter MacCallum Cancer Centre, University of Melbourne
Career Start Year 2005
Number of shared co-authors 60
Amirali Salmasi
University of California San Diego
Career Start Year 2005
Number of shared co-authors 9
Jonathan L Wright
University of Washington Medical Center
Career Start Year 2005
Number of shared co-authors 51
Thorsten Schlomm
Charite - University Hospital Berlin
Career Start Year 2004
Number of shared co-authors 34
Channing J Paller
Johns Hopkins University School of Medicine
Career Start Year 2004
Number of shared co-authors 39
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 38
Tim Dudderidge
University Hospital Southampton NHS Foundation Trust
Career Start Year 2002
Number of shared co-authors 40
Jun Hyuk Hong
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 2002
Number of shared co-authors 3
Vincent J Gnanapragasam
University of Cambridge
Career Start Year 1999
Number of shared co-authors 31
Evan Y Yu
University of Washington and Fred Hutchinson Cancer Research Center
Career Start Year 1997
Number of shared co-authors 69
Alan Thompson
The Royal Marsden NHS Foundation Trust
Career Start Year 1996
Number of shared co-authors 41
Inge M van Oort
Radboud University Medical Center
Career Start Year 1995
Number of shared co-authors 42
Louis Lacombe
CHU de Quebec-Universite Laval
Career Start Year 1994
Number of shared co-authors 33
Choung-Soo Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1993
Number of shared co-authors 10
Alexandre R Zlotta
University Health Network, Princess Margaret Cancer Center, University of Toronto
Career Start Year 1993
Number of shared co-authors 28
Byung Ha Chung
Yonsei University College of Medicine and Gangnam Severance Hospital
Career Start Year 1992
Number of shared co-authors 19
Nicolas Mottet
Hospitalier Universitaire de Saint-Etienne
Career Start Year 1989
Number of shared co-authors 45
Mark Frydenberg
Monash University
Career Start Year 1988
Number of shared co-authors 54
Theo M de Reijke
Amsterdam University Medical Centers, University of Amsterdam
Career Start Year 1987
Number of shared co-authors 44
Armen Aprikian
McGill University Health Centre, McGill University
Career Start Year 1987
Number of shared co-authors 30
Anders Bjartell
Skane University Hospital, Lund University
Career Start Year 1987
Number of shared co-authors 70
Eric J Bergstralh
Mayo Clinic
Career Start Year 1980
Number of shared co-authors 23
Yves Fradet
CHU de Quebec-Universite Laval
Career Start Year 1975
Number of shared co-authors 55
John Trachtenberg
University of Toronto, University Health Network
Career Start Year 1971
Number of shared co-authors 21

Collaborators

Patrick A Kupelian
university of california los angeles Medical Center
Co-authored papers 65
Chandana A Reddy
Cleveland Clinic
Co-authored papers 62
Jay P Ciezki
Cleveland Clinic
Co-authored papers 56
Ian M Thompson
CHRISTUS Santa Rosa Hospital-Medical Center
Co-authored papers 48
Elai Davicioni
Veracyte Inc.
Co-authored papers 42
Ashley E Ross
Northwestern University
Co-authored papers 38
Robert B Den
Thomas Jefferson University Hospital
Co-authored papers 33
Robert Jeffrey Karnes
Mayo Clinic
Co-authored papers 33
John S Witte
Stanford University School of Medicine
Co-authored papers 30
Edward M Schaeffer
Northwestern University Feinberg School of Medicine
Co-authored papers 24
Demetrius Albanes
Co-authored papers 23
Christopher A Haiman
University of Southern California
Co-authored papers 22
Sonja I Berndt
Co-authored papers 22
Stephen J Chanock
National Cancer Institute, National Institutes of Health
Co-authored papers 22
Janet L Stanford
Fred Hutchinson Cancer Research Center
Co-authored papers 21
Jeffrey J Tosoian
Vanderbilt University Medical Center
Co-authored papers 21
Bruce J Trock
Johns Hopkins University School of Medicine
Co-authored papers 20
John D Carpten
Co-authored papers 19
Scott M Lippman
Moores Cancer Center, university of california san diego
Co-authored papers 19
Stephen J Freedland
Cedars-Sinai Medical Center
Co-authored papers 19
Sue A Ingles
Co-authored papers 18
Wei Zheng
Co-authored papers 18
Nicholas Erho
GenomeDx Biosciences Inc.
Co-authored papers 18
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 18
Rahul D Tendulkar
Taussig Cancer Institute, Cleveland Clinic
Co-authored papers 18
Rick A Kittles
Morehouse School of Medicine
Co-authored papers 18
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 17
David V Conti
Co-authored papers 17
Esther M John
Co-authored papers 16
William J Blot
Vanderbilt University Medical Center
Co-authored papers 16
Release 1.2